FERC’s PJM Ruling and Affordability Push Could Be A Game Changer For Exelon (EXC)
Exelon Corporation EXC | 0.00 |
- In late April 2026, Exelon’s board declared a regular quarterly dividend of $0.42 per share, payable on June 15, 2026, to shareholders of record as of June 4, and the company voiced support for a Federal Energy Regulatory Commission order extending the PJM capacity price collar to help lower customer costs.
- At its 2026 annual meeting, Exelon highlighted a four-year $41.30 billion capital plan and earnings guidance through 2029 while advancing “The Exelon Promise,” which includes cost discipline, a $60 million Customer Relief Fund, and bill assistance for over 100,000 income-constrained customers.
- We’ll now examine how FERC’s PJM capacity price collar extension and Exelon’s affordability push may influence the company’s investment narrative.
This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
Exelon Investment Narrative Recap
To own Exelon, you need to be comfortable with a regulated utility story that balances large capital spending with close regulatory oversight and affordability pressures. The PJM capacity price collar extension and Exelon’s customer relief efforts align with this narrative, but do not materially change the key near term catalyst of new large load and grid investment approvals, nor the central risk that regulators could limit cost recovery and allowed returns.
The most relevant recent announcement here is Exelon’s four year US$41.30 billion capital plan paired with earnings guidance through 2029. That plan is closely tied to regulatory decisions on transmission, modernization, and affordability, so any shift in rate case outcomes or cost recovery rules could affect how much of that investment ultimately translates into earnings growth and support for the dividend.
Yet investors should also keep in mind the risk that rising grid and storm related costs may not be fully recoverable from regulators, which could...
Exelon’s narrative projects $27.1 billion revenue and $3.4 billion earnings by 2029. This requires 3.7% yearly revenue growth and a $0.6 billion earnings increase from $2.8 billion today.
Uncover how Exelon's forecasts yield a $50.17 fair value, a 9% upside to its current price.
Exploring Other Perspectives
Two fair value estimates from the Simply Wall St Community span a wide band, from about US$18.28 to US$50.17 per share, showing how far apart individual views can be. You can set those against the central risk of potentially less constructive rate outcomes, which could affect how effectively Exelon turns its planned US$41.30 billion of capital spending into earnings and dividend support over time.
Explore 2 other fair value estimates on Exelon - why the stock might be worth as much as 9% more than the current price!
Reach Your Own Conclusion
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Exelon research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
- Our free Exelon research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Exelon's overall financial health at a glance.
Looking For Alternative Opportunities?
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
- Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.
- The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- The latest GPUs need a type of rare earth metal called Terbium and there are only 30 companies in the world exploring or producing it. Find the list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
